Literature DB >> 2456367

Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.

D H Kono1, J L Urban, S J Horvath, D G Ando, R A Saavedra, L Hood.   

Abstract

Experimental allergic encephalomyelitis (EAE) is an autoimmune demyelinating disease of the central nervous system (CNS) that occurs after immunization of animals with myelin basic protein (MBP). The disease is a prototype model for the study of antigen-specific T helper cell-mediated autoimmune disease. In SJL/J mice, EAE is mediated by T helper cells directed against a 40-amino acid COOH-terminal peptic fragment of mouse small MBP. To identify the minimal T cell epitopes of MBP responsible for EAE, overlapping peptides completely encompassing the epitopes within this region were synthesized. A 28-residue peptide of mouse MBP spanning residues 87-114 (pM87-114) was able to elicit both a strong T cell response and chronic relapsing disease. To better localize the T cell epitopes, shorter peptides within this region were synthesized and two overlapping peptides, pM87-98 and pM91-104, were able to induce EAE. T cell clones and bulk lymph node cell populations reactive with pM87-98 did not respond to pM91-104. However, lymph node cells reactive with pM91-104 also reacted with pM87-98, thus showing that these two peptides represent contiguous, but distinct encephalitogenic epitopes and that both these epitopes may be contained within pM87-98. In addition, pM87-114 and pM87-98 were found to be minor determinants of the total T cell response to rat and rabbit MBP. The restricted response to MBP in SJL/J mice is similar to that of the PL/J mice in that each appears to have only a single peptide region in MBP that elicits encephalitogenic T cells. However, within the region studied, there were two if not more T cell epitopes. This differs from the single encephalitogenic PL/J epitope. These findings of a single encephalitogenic peptide region with multiple T cell epitopes and the fact that encephalitogenic T cell epitopes may be subdominant have implications for the design of treatments directed at the T cell receptor-MHC-peptide epitope complex in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456367      PMCID: PMC2188984          DOI: 10.1084/jem.168.1.213

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

Authors:  C B Pettinelli; D E McFarlin
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

2.  Clonal analysis of the BALB/c T cell proliferative response to apo beef cytochrome c.

Authors:  G Corradin; R H Zubler; H D Engers
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

3.  Variable synthesis and expression of E alpha and Ae (E beta) Ia polypeptide chains in mice of different H-2 haplotypes.

Authors:  P P Jones; D B Murphy; H O McDevitt
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes.

Authors:  D J Mathis; C Benoist; V E Williams; M Kanter; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pretreatment of the recipient.

Authors:  J D Taurog; G P Sandberg; M L Mahowald
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

6.  Experimental autoimmune encephalomyelitis in mice: immunologic response to mouse spinal cord and myelin basic proteins.

Authors:  C C Bernard; P R Carnegie
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

7.  Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant.

Authors:  R B Fritz; C H Chou; D E McFarlin
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice.

Authors:  A Ben-Nun; Z Lando
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation.

Authors:  E Heber-Katz; R H Schwartz; L A Matis; C Hannum; T Fairwell; E Appella; D Hansburg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  T cell clones reactive with sperm whale myoglobin. Isolation of clones with specificity for individual determinants on myoglobin.

Authors:  A J Infante; M Z Atassi; C G Fathman
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.

Authors:  Jia Li; Weian Chen; Yu'an Li; Ying Chen; Zhangna Ding; Dehao Yang; Xu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Amino acid variations at a single residue in an autoimmune peptide profoundly affect its properties: T-cell activation, major histocompatibility complex binding, and ability to block experimental allergic encephalomyelitis.

Authors:  V Kumar; J L Urban; S J Horvath; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism.

Authors:  D C Rayner; L D Petrycky-Cox; M Diocee; E Rector
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

Review 5.  MS as autoimmune disease: myelin antigens.

Authors:  W Fierz
Journal:  Res Immunol       Date:  1989-02

6.  Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms.

Authors:  Joel N H Stern; Zsolt Illés; Jayagopala Reddy; Derin B Keskin; Eric Sheu; Masha Fridkis-Hareli; Hiroyuki Nishimura; Celia F Brosnan; Laura Santambrogio; Vijay K Kuchroo; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

7.  Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis.

Authors:  C M Meyers; C J Kelly
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

8.  Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.

Authors:  Masha Fridkis-Hareli; Laura Santambrogio; Joel N H Stern; Lars Fugger; Celia Brosnan; Jack L Strominger
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

10.  The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.

Authors:  Andrew W Taylor; Nobuyoshi Kitaichi
Journal:  Brain Behav Immun       Date:  2008-01-02       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.